Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Helene Haguet is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogne, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), FAVRESSE, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogne, J.-M. (Co-supervisor), FAVRESSE, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research
-
Antifungal and Coagulation Properties of a Copper (I) Oxide Nanopowder Produced by Out-of-Phase Pulsed Sonoelectrochemistry
Mancier, V., Fattoum, S., Haguet, H., Laloy, J., Maillet, C., Gangloff, S. C. & Chopart, J.-P., 21 Mar 2024, In: Antibiotics. 13, 3, 286.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill
Dechamps, M., De Poortere, J., Octave, M., Ginion, A., Robaux, V., Pirotton, L., Bodart, J., Gruson, D., Van Dievoet, M.-A., Douxfils, J., Haguet, H., Morimont, L., Derive, M., Jolly, L., Bertrand, L., Laterre, P.-F., Horman, S. & Beauloye, C., 14 Apr 2023, In: International Journal of Molecular Sciences. 24, 8, 7278.Research output: Contribution to journal › Article › peer-review
Open AccessFile42 Downloads (Pure) -
Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients
Morimont, L., Dechamps, M., David, C., BOUVY, C., Gillot, C., Haguet, H., FAVRESSE, J., Ronvaux, L., Candiracci, J., Herzog , M., Laterre, P.-F., De Poortere, J., Horman, S., Beauloye, C. & Douxfils, J., 9 Jul 2022.Research output: Contribution to conference › Poster › peer-review
File27 Downloads (Pure) -
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Morimont, L., Dechamps, M., David, C., Bouvy, C., Gillot, C., Haguet, H., Favresse, J., Ronvaux, L., Candiracci, J., Herzog, M., Laterre, P.-F., De Poortere, J., Horman, S., Beauloye, C. & Douxfils, J., Aug 2022, In: Biomolecules. 12, 8, 1038.Research output: Contribution to journal › Article › peer-review
Open AccessFile38 Downloads (Pure) -
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Herzog , M., Morimont, L., Dechamps, M., David, C., Bouvy, C., Gillot, C., Haguet, H., Favresse, J., Ronvaux, L., Candiracci, J., Laterre, P.-F., De Poortere, J., Horman, S., Beauloye, C. & Douxfils, J., 13 Oct 2022.Research output: Contribution to conference › Poster › peer-review
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
-
ERAMET meeting
Hanquet, L. (Participant), Massaux, C. (Participant) & Haguet, H. (Contributor)
4 Mar 2024 → 5 Mar 2024Activity: Participating in or organising an event types › Participation in conference
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Morimont, L. (Contributor), Evrard, J. (Contributor), Siriez, R. (Contributor), Douxfils, J. (Contributor), Didembourg, M. (Participant), GILLOT, C. (Participant), Djokoto, H. (Participant) & Haguet, H. (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Evènements cardiovasculaires occlusifs associés aux inhibiteurs de tyrosine kinase ciblant BCR-ABL: Identification, compréhension et prédiction.
Haguet, H. (Speaker)
11 Feb 2022Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
Thesis
-
Association of cardiovascular occlusive events with BCR-ABL tyrosine kinase therapy: Identification, understanding and prediction
Haguet, H. (Author)Douxfils, J. (Supervisor), Mullier, F. (Co-Supervisor), Graux, C. (Jury), Dogne, J.-M. (Jury), Sonveaux, P. (Jury), Hainaut, P. (Jury), Saglio, G. (Jury) & Havelange, V. (Jury), 11 Feb 2022Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
File
Press/Media
-
Catholic University of Louvain (UCLouvain) Researcher Describes Recent Advances in COVID-19 (Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill)
Beauloye, C., Douxfils, J. & Haguet, H.
28/04/23
1 item of Media coverage
Press/Media: Expert Comment